Frequency of IDH1 mutation in adult-type diffuse astrocytic gliomas in a tertiary hospital in Kenya
The 2021 WHO classification of gliomas has separated gliomas based on their IDH mutation status, reflecting differences in their pathogenesis and clinical characteristics. There is a paucity of data on the prevalence of IDH mutations in gliomas in this region. This study aimed to determine the frequ...
Main Authors: | Samuel Gakinya, Anderson Mutuiri, Timothy Onyuma, Beverly Cheserem, Edwin Mogere |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-02-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2024.1305714/full |
Similar Items
-
The Role of ATRX in Glioma Biology
by: Pravanya Nandakumar, et al.
Published: (2017-09-01) -
Machine learning modeling of genome-wide copy number alteration signatures reliably predicts IDH mutational status in adult diffuse glioma
by: Nicholas Nuechterlein, et al.
Published: (2021-12-01) -
Implications of Concurrent <i>IDH1</i> and <i>IDH2</i> Mutations on Survival in Glioma—A Case Report and Systematic Review
by: Alexander Yuile, et al.
Published: (2022-10-01) -
GENETIC BIOMARKERS OF GLIAL BRAIN TUMORS: IDH1 AND IDH2 MUTATIONS
by: M. Yu. Prokudin, et al.
Published: (2020-09-01) -
IDH-1, ATRX AND 1P19Q CO-DELETION IN DIFFUSE GLIOMAS
by: Rabia Javed, et al.
Published: (2020-04-01)